Toxic Tort Litigation: Proving Causation in Chemical and Environmental Cases

The Science-Law Interface Where Billions Turn on Epidemiology

In 2012, a federal jury awarded $322 million to residents of Hinkley, California — the community made famous by the Erin Brockovich litigation — in a case built on chromium-6 contamination in groundwater. Toxic tort cases sit at the intersection of science and law, and the ability to translate epidemiological evidence into legally sufficient proof of causation determines whether plaintiffs win or walk away empty-handed. These cases involve chemical, environmental, or product exposures that allegedly caused disease, and they present causation challenges that no other area of civil litigation matches.

Toxic tort litigation has exploded since the 1970s asbestos wave. From benzene to PFAS "forever chemicals" to Camp Lejeune water contamination, the pattern is consistent: mass exposure, long latency period, disputed science, and corporate defendants with resources to fund years of litigation.

The Two Causation Hurdles

Unlike a car accident case where causation is immediate and obvious, toxic tort plaintiffs must clear two distinct causation gates before a jury can award damages:

• General causation: Can this substance cause this type of injury in humans at all? This is a population-level question answered by toxicology and epidemiology. Courts assess whether there is sufficient scientific evidence — peer-reviewed studies, dose-response relationships, biological plausibility — to establish that the chemical is capable of causing the disease at issue.
• Specific causation: Did this particular substance cause this particular plaintiff's disease? A plaintiff who developed leukemia near a benzene-emitting refinery must still show that their specific case was caused by that exposure rather than smoking history, genetic predisposition, or other sources.

Defendants routinely win toxic tort cases by attacking general causation — arguing that the science is not sufficiently settled to support expert testimony. The Daubert standard (established in Daubert v. Merrell Dow Pharmaceuticals, 1993) gives federal judges a gatekeeping role to exclude expert testimony that does not meet standards of scientific reliability.

The Role of Epidemiology

Epidemiological studies are the gold standard for establishing general causation in toxic tort cases. Courts look for:

A relative risk above 2.0 means the exposed group has more than twice the disease rate of unexposed controls — and courts have often used this as a practical threshold for inferring that "more likely than not" the exposure caused the individual plaintiff's disease. Glyphosate litigation, for example, produced heated disputes over whether the epidemiological evidence cleared this bar.

Class Actions in Toxic Tort Cases: The Complications

Class action certification under Federal Rule of Civil Procedure 23 requires that common questions of law or fact predominate over individual questions. In toxic tort cases, individual differences in exposure levels, medical histories, disease types, and damage amounts have led courts to deny or decertify class actions in many landmark cases. The Supreme Court's Amchem Products v. Windsor (1997) decision significantly restricted mass tort class actions, holding that divergent interests of present and future claimants — those already sick versus those who might become sick — precluded adequate class representation.

As a result, most large toxic tort cases now proceed as either: (1) mass consolidation in multidistrict litigation (MDL) coordinated in federal court for pretrial purposes with individual trials or bellwether cases, or (2) aggregate settlements negotiated after MDL proceedings establish liability trends through representative verdicts.

Key Defense Strategies

• Daubert challenges: Moving to exclude plaintiff's expert testimony as unreliable science before trial, potentially ending the case.
• Threshold arguments: Arguing that the plaintiff's exposure level was below the dose necessary to cause disease based on toxicological data.
• Alternative cause: Introducing evidence that other risk factors — lifestyle, genetics, other exposures — more plausibly caused the plaintiff's disease.
• Statutes of limitations: Arguing the discovery rule has expired because the plaintiff knew or should have known of the exposure-disease link earlier.

Major Toxic Tort Categories

This article is for informational purposes only and does not constitute legal advice.